Insight report on Sepsis – Pipeline Review, H2 2016 by consumer demands just published

“The Report Sepsis – Pipeline Review, H2 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. –”

Global Markets Directs, Sepsis – Pipeline Review, H2 2016, provides an overview of the Sepsis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sepsis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Sepsis and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Download Sample copy of this Report at :


– The report provides a snapshot of the global therapeutic landscape of Sepsis

– The report reviews pipeline therapeutics for Sepsis by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved Sepsis therapeutics and enlists all their major and minor projects

– The report assesses Sepsis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news related to pipeline therapeutics for Sepsis

Reasons to buy

– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of therapeutics under development for Sepsis

– Identify potential new clients or partners in the target demographic

– Develop strategic initiatives by understanding the focus areas of leading companies

– Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics

– Devise corrective measures for pipeline projects by understanding Sepsis pipeline depth and focus of Indication therapeutics

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

Table of Contents 2

List of Tables 7

List of Figures 9

Introduction 10

Global Markets Direct Report Coverage 10

Sepsis Overview 11

Therapeutics Development 12

Pipeline Products for Sepsis – Overview 12

Pipeline Products for Sepsis – Comparative Analysis 13

Sepsis – Therapeutics under Development by Companies 14

Sepsis – Therapeutics under Investigation by Universities/Institutes 19

Sepsis – Pipeline Products Glance 21

Late Stage Products 21

Clinical Stage Products 22

Early Stage Products 23

Unknown Stage Products 24

Sepsis – Products under Development by Companies 25

Sepsis – Products under Investigation by Universities/Institutes 30

Sepsis – Companies Involved in Therapeutics Development 31

Adrenomed AG 31

Altor BioScience Corporation 32

Am-Pharma B.V. 33

Arch Biopartners, Inc. 34

Aridis Pharmaceuticals LLC 35

Asahi Kasei Pharma Corp. 36

Astellas Pharma Inc. 37

Batu Biologics, Inc. 38

Biomedica Management Corporation 39

Boehringer Ingelheim GmbH 40

Bristol-Myers Squibb Company 41

Cell2B S.A. 42

Chiesi Farmaceutici SpA 43

Chiome Bioscience, Inc. 44

Cilian AG 45

Cognosci, Inc. 46

Cytheris SA 47

Endacea, Inc. 48

Evec, Inc. 49

Huons Co., Ltd. 50

Immune Response BioPharma, Inc. 51

Immunethep, SA 52

ImmunNovative Developments SL 53

InflaRx GmbH 54

Inotrem S.A. 55

Integrated BioTherapeutics, Inc. 56

Lead Discovery Center GmbH 57

Follow us on LinkedIn:

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074